US4499069A - Antiperspirant emulsion - Google Patents
Antiperspirant emulsion Download PDFInfo
- Publication number
- US4499069A US4499069A US06/464,663 US46466383A US4499069A US 4499069 A US4499069 A US 4499069A US 46466383 A US46466383 A US 46466383A US 4499069 A US4499069 A US 4499069A
- Authority
- US
- United States
- Prior art keywords
- antiperspirant
- stable
- stearyl ether
- polyethylene glycol
- emulsifier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003213 antiperspirant Substances 0.000 title claims abstract description 42
- 230000001166 anti-perspirative effect Effects 0.000 title claims abstract description 41
- 239000000839 emulsion Substances 0.000 title claims abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract description 64
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 26
- 125000004122 cyclic group Chemical group 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 19
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 19
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 claims abstract description 18
- 150000003839 salts Chemical class 0.000 claims abstract description 18
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 14
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000007957 coemulsifier Substances 0.000 claims abstract description 6
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229910052726 zirconium Inorganic materials 0.000 claims abstract description 5
- 239000003974 emollient agent Substances 0.000 claims description 8
- 239000011358 absorbing material Substances 0.000 claims description 5
- 229920001451 polypropylene glycol Polymers 0.000 claims description 4
- 229940099583 aluminum starch octenylsuccinate Drugs 0.000 claims description 3
- 238000009472 formulation Methods 0.000 description 17
- 239000000463 material Substances 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 7
- 239000012071 phase Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 description 5
- WWHZEXDIQCJXSV-UHFFFAOYSA-N aluminum;trihypochlorite Chemical compound [Al+3].Cl[O-].Cl[O-].Cl[O-] WWHZEXDIQCJXSV-UHFFFAOYSA-N 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- IPCAPQRVQMIMAN-UHFFFAOYSA-L zirconyl chloride Chemical compound Cl[Zr](Cl)=O IPCAPQRVQMIMAN-UHFFFAOYSA-L 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- ADGFKRMKSIAMAI-UHFFFAOYSA-L oxygen(2-);zirconium(4+);chloride;hydroxide Chemical compound [OH-].[O-2].[Cl-].[Zr+4] ADGFKRMKSIAMAI-UHFFFAOYSA-L 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000013638 trimer Substances 0.000 description 2
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- ZGUQGPFMMTZGBQ-UHFFFAOYSA-N [Al].[Al].[Zr] Chemical compound [Al].[Al].[Zr] ZGUQGPFMMTZGBQ-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- PQLAYKMGZDUDLQ-UHFFFAOYSA-K aluminium bromide Chemical compound Br[Al](Br)Br PQLAYKMGZDUDLQ-UHFFFAOYSA-K 0.000 description 1
- BWZOPYPOZJBVLQ-UHFFFAOYSA-K aluminium glycinate Chemical compound O[Al+]O.NCC([O-])=O BWZOPYPOZJBVLQ-UHFFFAOYSA-K 0.000 description 1
- -1 aluminum chlorhydroxides Chemical class 0.000 description 1
- 229940048506 aluminum zirconium tetrachlorohydrex gly Drugs 0.000 description 1
- HAMGNFFXQJOFRZ-UHFFFAOYSA-L aluminum;zirconium(4+);chloride;hydroxide;hydrate Chemical compound O.[OH-].[Al+3].[Cl-].[Zr+4] HAMGNFFXQJOFRZ-UHFFFAOYSA-L 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- ZYYRAHJUNAIHTP-UHFFFAOYSA-A dialuminum;zirconium(4+);heptachloride;heptahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Zr+4].[Zr+4] ZYYRAHJUNAIHTP-UHFFFAOYSA-A 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 101150035983 str1 gene Proteins 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/28—Zirconium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
Definitions
- This invention relates to antiperspirant emulsions and more particularly to stable antiperspirant emulsions containing major portions of volatile cyclic silicone, water, and antiperspirant salts.
- Antiperspirant compositions adapted for roll-on application which have achieved substantial consumer acceptance include such compositions as are described, for example, in British patent application No. GB 2018590 A.
- Such compositions are substantially anhydrous and comprise a powdered antiperspirant agent suspended in a liquid hydrophobic volatile silicone vehicle (generally 60 to 95% by weight) which includes a hydrophobic suspending agent, the composition containing less than 4% of other hydrophobic liquids which are less volatile than the cyclic silicone.
- a liquid hydrophobic volatile silicone vehicle generally 60 to 95% by weight
- a hydrophobic suspending agent the composition containing less than 4% of other hydrophobic liquids which are less volatile than the cyclic silicone.
- an object of the invention to provide an antiperspirant composition in which the advantages associated with volatile cyclic silicones are maintained while substituting an inexpensive replacement for a major portion thereof.
- a further and more specific object of the invention is to provide a stable antiperspirant emulsion including volatile cyclic silicone, water, and antiperspirant salts.
- a stable antiperspirant emulsion in which, unexpectedly, a surfactant mixture containing polyethylene glycol (21) stearyl ether affords excellent stability, while as indicated previously, the closely-related polyethylene glycol (20) stearyl ether does not.
- Stable antiperspirant emulsions include from about 5% to about 25% of an antiperspirant salt of aluminum or zirconium or combinations thereof, from about 15% to about 25% of a volatile cyclic silicone from about 2% to about 10% of a low pH-stable emulsifier mixture which comprises polyethylene glycol (21) stearyl ether and a lipophilic co-emulsifier such that the HLB of the emulsifier mixture is more than 7.5 and less than 9.9, and from about 35% to about 78% water, the percentages being by weight based on the total weight of the composition.
- the composition may include up to about 3% of a low pH-stable emollient capable of reducing the tackiness associated with antiperspirant salts, and up to about 3% of an oil-absorbing material.
- the antiperspirant salts of aluminum and/or zirconium may be selected from the various materials of this nature available. Suitable such materials are, for example, aluminum chloride, aluminum chlorhydroxide, basic aluminum bromide, zirconyl chloride, zirconyl hydroxide, complexes of aluminum hydroxide, zirconyl chloride and aluminum chlorhydroxide, complexes of aluminum hydroxide, zirconyl hydroxychloride and aluminum chlorhydroxide, complexes of dihydroxyaluminum glycinate, zirconyl chloride and/or zirconyl hydroxychloride and aluminum chlorhydroxides, complexes of zirconyl chloride and/or zirconyl hydroxychloride with aluminum chlorhydroxide and an amino acid, such as glycine (as a buffering agent), and mixtures of two or more of the above.
- an amino acid such as glycine (as a buffering agent)
- the antiperspirant used is generally soluble in water, but insoluble in the volatile cyclic silicone, which is hydrophobic.
- the amount of antiperspirant present may be varied to suit particular needs.
- the compositions will comprise from about 5 to 25% antiperspirant by weight, and preferably from about 15 to 20% by weight, of the composition. There must be enough of the active material present for the composition to be effective as an antiperspirant. On the other hand it is expected that concentrations above about 20-25% of the antiperspirant salt will be outside regulatory limits.
- a particularly effective antiperspirant salt designated according to its Cosmelic, Toiletry and Fragrance Association (CTFA) adopted name, is aluminum zirconium tetrachlorohydrex gly, which is a coordination complex of aluminum zirconium tetrachlorohydrate and glycine in which some of the water molecules normally coordinated to the metals have been displaced by the glycine. This material is available commercially from Wickhen Products under the designation WICKENOL 368, 369, or 374.
- volatile cyclic silicones which are used in the composition of the present invention are well known and have been generally taught to be useful in antiperspirant formulations.
- volatile cyclic silicones may be represented by the formula: ##STR1## wherein R is a 1 to 3 carbon alkyl group, n is a number from 3 to 10, preferably from 3 to 7, and the unsatisfied valences on the oxygen and silicon atoms at the ends of the chain are joined to one another to form a cyclic structure.
- Suitable volatile cyclic silicones are, for example, (a) U.C.C.
- Typical vapor pressures of the volatile cyclic silicones are shown in Table 1 below wherein the vapor pressures for Dow Corning 344 fluid at various temperatures are set forth.
- compositions according to the present invention the amount of volatile cyclic silicone will be reduced as much as practicable from the amounts disclosed in the above-mentioned British patent application No. GB 2018590 A, in order to realize maximum cost savings, but not so much as to sacrifice the pleasant feel and quick drying properties afforded by its use.
- the compositions will preferably contain from about 15% to about 25% of the volatile cyclic silicone; 18% to 22% gave particularly good results.
- the emulsifer mixture includes polyethylene glycol (21) stearyl ether as the critical component.
- This material may be defined as the glycol ether of stearyl alcohol that conforms to the formula CH 3 (CH 2 ) 16 (OCH 2 CH 2 ) n OH where n has an average value of 21. It is available from ICI Americas under the name BRIJ 721 and, as an ether-linked ethoxylate, is quite stable in the acid pH environment characteristic of the antiperspirant salts.
- HLB 15.5 and so is combined with an acid-stable lipophilic co-emulsifier in order to achieve HLB greater than 7.5 and less than 9.9, the range preferred according to the present invention, the range 7.8 to 8.2 being especially preferred.
- acid stability is required of the co-emulsifier
- another ether-linked ethoxylate is a preferred choice, with polyethylene glycol (2) stearyl ether being especially preferred.
- polyethylene glycol (2) stearyl ether examples include BRIJ 72, sold by ICI Americas, Volpo S.2, sold by Croda, and Lipocol S-2, sold by Lipo Chemicals.
- At least about 2% of the emulsifier mixture is required to obtain a stable emulsion of water and volatile cyclic silicone (and other oily material) in the presence of the antiperspirant salt. More than about 5% is unnecessary and would also tend to give the composition a greasy feel and might make it too viscous to use as a roll-on antiperspirant. However such compositions with higher concentration of emulsifier could be useful in other application forms such as creams, in which case up to about 10% of the emulsifier mixture might be used. Particularly preferred for a roll-on product is an emulsifier mixture concentration of 2.5% to 4%.
- compositions according to the present invention may optionally contain additional ingredients to reduce tackiness and any oily or greasy feel.
- Certain low pH-stable emollients are found to have the ability to reduce the tackiness associated with antiperspirant salts, a particularly effective example of such a material being polypropylene glycol (15) stearyl ether, which is the polypropylene glycol ether of stearyl alcohol according to the formula ##STR2## where n has an average value of 15.
- This material may be obtained, for example, from ICI Americas under the designation ARLAMOL E or from Heterene Chemical Company as HETOXOL SP-15.
- the emollient if present, is preferably used at a concentration of about 1% to 3% of the total composition, with a concentration of 1.5% to 2% most preferred. Excess oiliness may be reduced by the use of up to 3%, preferably 1% to 3%, and more preferably 1.5% to 2.5%, of an oil-absorbent material, aluminum starch octenylsuccinate (available from National Starch under the name "Dry Flo") being a representative example of such a material.
- an oil-absorbent material aluminum starch octenylsuccinate (available from National Starch under the name "Dry Flo" being a representative example of such a material.
- oil phase ingredients (1-6) were mixed at 70° C. and the water phase ingredients (7-9) mixed at 72° C. Then the aqueous phase was added to the oil phase at about 70° C. with low-shear mixing until homogeneous, taking care not to whip air into the emulsion.
- Formulations C-F After four weeks of storage under the conditions described above, Formulations C-F all developed about a one-inch separated layer, which while easily redispersed on shaking, may be considered only borderline acceptability.
- Formulation G under the same conditions developed virtually no separation (less than 1/2 mm layer at the bottom, which easily redispersed) and had a viscosity of 7000 cps, somewhat viscous but still acceptable for roll-on application.
- Formulation H exhibited no separation and was in the form of a smooth off-white cream, having a viscosity of about 25,000 cps shortly after preparation and rising gradually to and stabilizing at about 30,000 cps.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
A stable antiperspirant emulsion is disclosed which contains an antiperspirant salt of aluminum and/or zirconium, volatile cyclic silicone, water, and a low pH-stable emulsifier mixture of polyethylene glycol (21) stearyl ether and a lipophilic co-emulsifier such that the HLB of the emulsifier mixture is more than 7.5 and less than 9.9.
Description
1. Field of the Invention
This invention relates to antiperspirant emulsions and more particularly to stable antiperspirant emulsions containing major portions of volatile cyclic silicone, water, and antiperspirant salts.
2. Description of the Prior Art
Antiperspirant compositions adapted for roll-on application which have achieved substantial consumer acceptance include such compositions as are described, for example, in British patent application No. GB 2018590 A. Such compositions are substantially anhydrous and comprise a powdered antiperspirant agent suspended in a liquid hydrophobic volatile silicone vehicle (generally 60 to 95% by weight) which includes a hydrophobic suspending agent, the composition containing less than 4% of other hydrophobic liquids which are less volatile than the cyclic silicone. These compositions have excellent "feel," are neither sticky nor tacky, apply smoothly, and dry quickly.
Having achieved these desirable properties, it would nevertheless be avantageous to the formulator to reduce the cost of the composition described above by replacing the expensive volatile cyclic silicone, or at least a major portion thereof, with water, while at the same time avoiding a sacrifice of the above-mentioned desired properties. This goal might be achieved by retaining some of the silicone, for the quick drying and good "feel" it affords to the product, while providing a stable emulsion with a major portion of water, in the presence of the antiperspirant ingredient.
Such an approach has been proposed, for example, in a publication of the Product Development Department of ICI Americas Inc., entitled "Antiperspirants: Functionality and Benefits of ICI Americas' Surfactants and Emollients" (1980), wherein at page 32 it is proposed to emulsify a quick-drying aluminum chlorhydroxide antiperspirant lotion including volatile cyclic silicone and water with a surfactant mixture of polyethylene glycol (2) cetyl ether and polyethylene glycol (23) lauryl ether, which surfactants are present in a ratio of 3.4:1 and together account for 4% by weight of the total composition. Although the volatile silicone requires HLB 8 and the surfactant mixture described can be shown to have HLB32 7.9, the emulsion is not stable. Further attempts to create a stable antiperspirant emulsion of volatile cyclic silicone and water, using a surfactant mixture at HLB 8 of polyethylene glycol (20) stearyl ether or polyethylene glycol (20) cetyl ether, together with polyethylene glycol (2) stearyl ether, also were not successful.
Accordingly, it is an object of the invention to provide an antiperspirant composition in which the advantages associated with volatile cyclic silicones are maintained while substituting an inexpensive replacement for a major portion thereof.
A further and more specific object of the invention is to provide a stable antiperspirant emulsion including volatile cyclic silicone, water, and antiperspirant salts.
With the above objects in view, according to the present invention there is provided a stable antiperspirant emulsion in which, unexpectedly, a surfactant mixture containing polyethylene glycol (21) stearyl ether affords excellent stability, while as indicated previously, the closely-related polyethylene glycol (20) stearyl ether does not. Stable antiperspirant emulsions according to the invention include from about 5% to about 25% of an antiperspirant salt of aluminum or zirconium or combinations thereof, from about 15% to about 25% of a volatile cyclic silicone from about 2% to about 10% of a low pH-stable emulsifier mixture which comprises polyethylene glycol (21) stearyl ether and a lipophilic co-emulsifier such that the HLB of the emulsifier mixture is more than 7.5 and less than 9.9, and from about 35% to about 78% water, the percentages being by weight based on the total weight of the composition. Optionally the composition may include up to about 3% of a low pH-stable emollient capable of reducing the tackiness associated with antiperspirant salts, and up to about 3% of an oil-absorbing material.
The antiperspirant salts of aluminum and/or zirconium may be selected from the various materials of this nature available. Suitable such materials are, for example, aluminum chloride, aluminum chlorhydroxide, basic aluminum bromide, zirconyl chloride, zirconyl hydroxide, complexes of aluminum hydroxide, zirconyl chloride and aluminum chlorhydroxide, complexes of aluminum hydroxide, zirconyl hydroxychloride and aluminum chlorhydroxide, complexes of dihydroxyaluminum glycinate, zirconyl chloride and/or zirconyl hydroxychloride and aluminum chlorhydroxides, complexes of zirconyl chloride and/or zirconyl hydroxychloride with aluminum chlorhydroxide and an amino acid, such as glycine (as a buffering agent), and mixtures of two or more of the above. The antiperspirant used is generally soluble in water, but insoluble in the volatile cyclic silicone, which is hydrophobic. The amount of antiperspirant present may be varied to suit particular needs. In general, the compositions will comprise from about 5 to 25% antiperspirant by weight, and preferably from about 15 to 20% by weight, of the composition. There must be enough of the active material present for the composition to be effective as an antiperspirant. On the other hand it is expected that concentrations above about 20-25% of the antiperspirant salt will be outside regulatory limits. (As used herein these antiperspirant salt concentrations are based upon equivalent amounts of the particular hydrated salt.) A particularly effective antiperspirant salt, designated according to its Cosmelic, Toiletry and Fragrance Association (CTFA) adopted name, is aluminum zirconium tetrachlorohydrex gly, which is a coordination complex of aluminum zirconium tetrachlorohydrate and glycine in which some of the water molecules normally coordinated to the metals have been displaced by the glycine. This material is available commercially from Wickhen Products under the designation WICKENOL 368, 369, or 374.
The volatile cyclic silicones which are used in the composition of the present invention are well known and have been generally taught to be useful in antiperspirant formulations. Generally such volatile cyclic silicones may be represented by the formula: ##STR1## wherein R is a 1 to 3 carbon alkyl group, n is a number from 3 to 10, preferably from 3 to 7, and the unsatisfied valences on the oxygen and silicon atoms at the ends of the chain are joined to one another to form a cyclic structure. Suitable volatile cyclic silicones are, for example, (a) U.C.C. Y-7207 sold by Union Carbide Corporation in which each R is methyl and which typically comprises by weight 99.4% tetramer, 0.6% trimer and traces of the pentamer and hexamer; (b) SWS-03314 (sold by SWS Silicones, a Division of Stauffer Chemical Company) in which R is methyl and which is substantially all tetramer; and (c) Dow Corning 344 fluid in which R is methyl and which typically comprises by weight about 88% tetramer, about 11.8% pentamer and traces of trimer and hexamer.
Typical vapor pressures of the volatile cyclic silicones are shown in Table 1 below wherein the vapor pressures for Dow Corning 344 fluid at various temperatures are set forth.
TABLE 1 ______________________________________ Temperature Vapor Pressure, mmHg ______________________________________ 26° C. 1 64° C. 10 77° C. 20 92° C. 40 101° C. 60 114° C. 100 155° C. 400 178° C. 760 ______________________________________
In compositions according to the present invention the amount of volatile cyclic silicone will be reduced as much as practicable from the amounts disclosed in the above-mentioned British patent application No. GB 2018590 A, in order to realize maximum cost savings, but not so much as to sacrifice the pleasant feel and quick drying properties afforded by its use. According to the invention, the compositions will preferably contain from about 15% to about 25% of the volatile cyclic silicone; 18% to 22% gave particularly good results.
The emulsifer mixture, as previously indicated, includes polyethylene glycol (21) stearyl ether as the critical component. This material may be defined as the glycol ether of stearyl alcohol that conforms to the formula CH3 (CH2)16 (OCH2 CH2)n OH where n has an average value of 21. It is available from ICI Americas under the name BRIJ 721 and, as an ether-linked ethoxylate, is quite stable in the acid pH environment characteristic of the antiperspirant salts. It has HLB=15.5 and so is combined with an acid-stable lipophilic co-emulsifier in order to achieve HLB greater than 7.5 and less than 9.9, the range preferred according to the present invention, the range 7.8 to 8.2 being especially preferred. Since, as indicated, acid stability is required of the co-emulsifier, another ether-linked ethoxylate is a preferred choice, with polyethylene glycol (2) stearyl ether being especially preferred. Examples of the latter material include BRIJ 72, sold by ICI Americas, Volpo S.2, sold by Croda, and Lipocol S-2, sold by Lipo Chemicals. At least about 2% of the emulsifier mixture is required to obtain a stable emulsion of water and volatile cyclic silicone (and other oily material) in the presence of the antiperspirant salt. More than about 5% is unnecessary and would also tend to give the composition a greasy feel and might make it too viscous to use as a roll-on antiperspirant. However such compositions with higher concentration of emulsifier could be useful in other application forms such as creams, in which case up to about 10% of the emulsifier mixture might be used. Particularly preferred for a roll-on product is an emulsifier mixture concentration of 2.5% to 4%.
Compositions according to the present invention may optionally contain additional ingredients to reduce tackiness and any oily or greasy feel. Certain low pH-stable emollients are found to have the ability to reduce the tackiness associated with antiperspirant salts, a particularly effective example of such a material being polypropylene glycol (15) stearyl ether, which is the polypropylene glycol ether of stearyl alcohol according to the formula ##STR2## where n has an average value of 15. This material may be obtained, for example, from ICI Americas under the designation ARLAMOL E or from Heterene Chemical Company as HETOXOL SP-15. The emollient, if present, is preferably used at a concentration of about 1% to 3% of the total composition, with a concentration of 1.5% to 2% most preferred. Excess oiliness may be reduced by the use of up to 3%, preferably 1% to 3%, and more preferably 1.5% to 2.5%, of an oil-absorbent material, aluminum starch octenylsuccinate (available from National Starch under the name "Dry Flo") being a representative example of such a material.
In addition to the above-described ingredients small quantities of such additional materials as preservatives and a perfume may also be present.
In order that the invention may be more fully understood, the following examples are given by way of illustration only. All parts and percentages are by weight.
Two antiperspirant formulations were made up comprising the following ingredients:
______________________________________ % by Weight Formulation Formulation Ingredient A B ______________________________________ 1. Dow Corning 344 20.00 20.00 Silicone 2. Brij 72 2.20 2.20 3a. Polyethylene Glycol (21) 1.00 -- Stearyl Ether 3b. Polyethylene Glycol (20) -- 1.00 Stearyl Ether 4. Arlamol E 1.80 1.80 5. Aluminum Starch Octenyl- 2.00 2.00 succinate 6. Butylparaben 0.15 0.15 7. Aluminum Zirconium Tetra- 57.10* 57.10* chlorohydrex Gly, 35% Aqueous Solution 8. Deionized Water 15.65** 15.65** 9. Methylparaben 0.10 0.10 ______________________________________ *Corresponds to 20% by weight of the hydrated salt. **Total water is 52.75% by weight.
The oil phase ingredients (1-6) were mixed at 70° C. and the water phase ingredients (7-9) mixed at 72° C. Then the aqueous phase was added to the oil phase at about 70° C. with low-shear mixing until homogeneous, taking care not to whip air into the emulsion.
Stability of each emulsion was tested by filling it into a 250 ml wide-mouth jar, capping, and storing at 45° C., checking the appearance of the jar contents at regular intervals for emulsion separation. After four weeks of storage under the above conditions Formulation A had developed a small (2-3 mm) mostly water layer at the bottom containing a small amount of starch, with the remainder a milky liquid into which the small water layer was easily redispersed. After the same interval Formulation B, by contrast, showed extreme separation of the oil and water phases with, from the bottom, 2-3 mm starch, about 30 mm of a water phase layer, about 30 mm of an oil phase layer, and on top about 2-3 mm of another oil layer, mostly silicone; and vigorous shaking would not redisperse the contents.
Additional antiperspirant formulations were prepared similar to Formulation A, varying the proportions of polyethylene glycol (21) stearyl ether and Brij 72, adjusting only the water to maintain the total of all ingredients at 100%:
______________________________________ Polyethylene Glycol (21) Stearyl Ether Brij 72 HLB ______________________________________ Formulation C 1.60% 1.80% 9.9 Formulation D 1.30 1.50 9.8 Formulation E 1.40 1.60 9.9 Formulation F 1.50 1.70 9.9 Formulation G 1.56 3.44 8.2 Formulation H 2.50 5.50 8.2 ______________________________________
After four weeks of storage under the conditions described above, Formulations C-F all developed about a one-inch separated layer, which while easily redispersed on shaking, may be considered only borderline acceptability. Formulation G under the same conditions developed virtually no separation (less than 1/2 mm layer at the bottom, which easily redispersed) and had a viscosity of 7000 cps, somewhat viscous but still acceptable for roll-on application. Formulation H exhibited no separation and was in the form of a smooth off-white cream, having a viscosity of about 25,000 cps shortly after preparation and rising gradually to and stabilizing at about 30,000 cps.
Claims (15)
1. A stable antiperspirant emulsion consisting essentially of:
(a) from about 5% to about 25% of an antiperspirant salt of aluminum or zirconium or combinations thereof,
(b) from about 15% to about 25% of a volatile cyclic silicone,
(c) from about 2% to about 10% of a low pH-stable emulsifier mixture which comprises polyethylene glycol (21) stearyl ether and a lipophilic co-emulsifier such that the HLB of the emulsifier mixture is more than 7.5 and less than 9.9, and
(d) from about 35% to about 78% of water, said percentages being by weight based on the total weight of the composition.
2. The antiperspirant emulsion of claim 1, further including up to about 3% of a low pH-stable emollient adapted to reduce antiperspirant salt tackiness.
3. The antiperspirant emulsion of claim 1, further inlcuding up to about 3% of an oil-absorbing material.
4. The invention of claim 1 wherein said lipophilic co-emulsifier is polyethylene glycol (2) stearyl ether.
5. The invention of claim 4 wherein said emulsifier mixture comprises from about 2.5% to about 4.0% of the total composition.
6. The invention of claim 1 wherein the HLB of the emulsifier mixture is from 7.8 to 8.2.
7. The invention of claim 1 wherein the volatile cyclic silicone comprises from about 18% to about 22% of the total composition.
8. The invention of claim 2 wherein said emollient comprises from about 1% to about 3% of the total composition.
9. The invention of claim 2 wherein said emollient comprises from about 1.5% to about 2% of the total composition.
10. The invention of claim 8 wherein said emollient is polypropylene glycol (15) stearyl ether.
11. The invention of claim 3 wherein said oil-absorbing material comprises from about 1% to about 3% of the total composition.
12. The invention of claim 3 wherein said oil-absorbing material comprises from about 1.5 to about 2.5% of the total composition.
13. The invention of claim 11 wherein said oil-absorbing material is aluminum starch octenylsuccinate.
14. The invention of claim 1 wherein said antiperspirant salt comprises from about 15% to about 20% of lhe total composition.
15. A stable antiperspirant emulsion comprising:
(a) from about 15% to about 20% of an antiperspirant salt of aluminum or zirconium or combinations thereof,
(b) from about 18% to about 22% of a volatile cyclic silicone,
(c) from about 2.5% to about 4.0% of a low pH-stable emulsifier mixture which comprises polyethylene glycol (21) stearyl ether and polyethylene glycol (2) stearyl ether such that the HLB of the emulsifier mixture is from 7.8 to 8.2,
(d) from about 1.5% to about 2.0% of polypropylene glycol (15) stearyl ether,
(e) from about 1.5% to about 2.5% of aluminum starch octenylsuccinate, and
(f) from about 45% to about 63% water.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/464,663 US4499069A (en) | 1983-02-07 | 1983-02-07 | Antiperspirant emulsion |
CA000446444A CA1208136A (en) | 1983-02-07 | 1984-01-31 | Antiperspirant emulsion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/464,663 US4499069A (en) | 1983-02-07 | 1983-02-07 | Antiperspirant emulsion |
Publications (1)
Publication Number | Publication Date |
---|---|
US4499069A true US4499069A (en) | 1985-02-12 |
Family
ID=23844800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US06/464,663 Expired - Lifetime US4499069A (en) | 1983-02-07 | 1983-02-07 | Antiperspirant emulsion |
Country Status (2)
Country | Link |
---|---|
US (1) | US4499069A (en) |
CA (1) | CA1208136A (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4900542A (en) * | 1985-03-20 | 1990-02-13 | Carter-Wallace Inc. | Manufacturing process for microcrystalline emulsions |
US4944938A (en) * | 1988-12-16 | 1990-07-31 | Colgate-Palmolive Company | Antiperspirant and deodorant |
US4948578A (en) * | 1987-05-15 | 1990-08-14 | Lever Brothers Company | Transparent antiperspirant stick compositions |
US5008103A (en) * | 1988-12-29 | 1991-04-16 | General Electric Company | Silicone surfactants |
WO1995003781A1 (en) * | 1993-07-03 | 1995-02-09 | The Procter & Gamble Company | Personal cleansing compositions |
US5409694A (en) * | 1991-07-18 | 1995-04-25 | Procter & Gamble | Liquid deodorant compositions |
US5487887A (en) * | 1993-10-28 | 1996-01-30 | Bristol-Myers Squibb Company | Clear antiperspirant roll-on compositions |
US5534246A (en) * | 1994-08-29 | 1996-07-09 | Helene Curtis, Inc. | Topically-effective compositions |
US5575990A (en) * | 1993-10-28 | 1996-11-19 | Bristol-Myers Squibb Company | Antiperspirant roll-on compositions |
WO1998032418A1 (en) * | 1997-01-29 | 1998-07-30 | The Gillette Company | Clear antiperspirant or deodorant gel composition with volatile linear silicone to reduce staining |
US5919437A (en) * | 1996-05-24 | 1999-07-06 | Colgate-Palmolive Company | Cosmetic cream composition containing silicone gel material |
US5989536A (en) * | 1993-07-03 | 1999-11-23 | The Procter & Gamble Company | Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin |
WO2001047488A3 (en) * | 1999-12-24 | 2002-01-24 | Henkel Kgaa | Antiperspirant composition that contains a water-soluble antiperspirant active agent |
WO2001047476A3 (en) * | 1999-12-24 | 2002-06-06 | Henkel Kgaa | Antiperspirant composition |
US6685952B1 (en) | 1999-06-25 | 2004-02-03 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Personal care compositions and methods-high internal phase water-in-volatile silicone oil systems |
US20040109833A1 (en) * | 2002-12-09 | 2004-06-10 | Xiaozhong Tang | High efficacy, low irritation aluminum salts and related products |
US20070190012A1 (en) * | 2004-04-15 | 2007-08-16 | Dow Corning S.A. | Low molecular weight silicone oil-in-water emulsion |
WO2007124889A2 (en) | 2006-04-28 | 2007-11-08 | Henkel Ag & Co. Kgaa | Quick-drying cosmetic emulsions for roll-on application |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4122029A (en) * | 1977-07-27 | 1978-10-24 | Dow Corning Corporation | Emulsion compositions comprising a siloxane-oxyalkylene copolymer and an organic surfactant |
GB2018590A (en) * | 1978-04-14 | 1979-10-24 | Gillette Co | Antiperspirant compositions |
US4264586A (en) * | 1976-01-28 | 1981-04-28 | Lever Brothers Company | Antiperspirant emulsion |
US4268499A (en) * | 1979-06-07 | 1981-05-19 | Dow Corning Corporation | Antiperspirant emulsion compositions |
US4350605A (en) * | 1977-11-22 | 1982-09-21 | Peterson/Puritan, Inc. | Water-in-oil emulsions |
-
1983
- 1983-02-07 US US06/464,663 patent/US4499069A/en not_active Expired - Lifetime
-
1984
- 1984-01-31 CA CA000446444A patent/CA1208136A/en not_active Expired
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4264586A (en) * | 1976-01-28 | 1981-04-28 | Lever Brothers Company | Antiperspirant emulsion |
US4122029A (en) * | 1977-07-27 | 1978-10-24 | Dow Corning Corporation | Emulsion compositions comprising a siloxane-oxyalkylene copolymer and an organic surfactant |
US4350605A (en) * | 1977-11-22 | 1982-09-21 | Peterson/Puritan, Inc. | Water-in-oil emulsions |
GB2018590A (en) * | 1978-04-14 | 1979-10-24 | Gillette Co | Antiperspirant compositions |
US4268499A (en) * | 1979-06-07 | 1981-05-19 | Dow Corning Corporation | Antiperspirant emulsion compositions |
Non-Patent Citations (1)
Title |
---|
Bulletin of ICI Americas Inc., entitled Antiperspirants: Functionality and Benefits of ICI Americas Surfactants and Emollients, 1980. * |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4900542A (en) * | 1985-03-20 | 1990-02-13 | Carter-Wallace Inc. | Manufacturing process for microcrystalline emulsions |
US4948578A (en) * | 1987-05-15 | 1990-08-14 | Lever Brothers Company | Transparent antiperspirant stick compositions |
US4944938A (en) * | 1988-12-16 | 1990-07-31 | Colgate-Palmolive Company | Antiperspirant and deodorant |
AU634732B2 (en) * | 1988-12-16 | 1993-03-04 | Colgate-Palmolive Company, The | Antiperspirant and deodorant |
US5008103A (en) * | 1988-12-29 | 1991-04-16 | General Electric Company | Silicone surfactants |
US5409694A (en) * | 1991-07-18 | 1995-04-25 | Procter & Gamble | Liquid deodorant compositions |
CN1079665C (en) * | 1993-07-03 | 2002-02-27 | 普罗克特和甘保尔公司 | Personal cleansing compositions |
US5989536A (en) * | 1993-07-03 | 1999-11-23 | The Procter & Gamble Company | Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin |
WO1995003781A1 (en) * | 1993-07-03 | 1995-02-09 | The Procter & Gamble Company | Personal cleansing compositions |
US5575990A (en) * | 1993-10-28 | 1996-11-19 | Bristol-Myers Squibb Company | Antiperspirant roll-on compositions |
US5487887A (en) * | 1993-10-28 | 1996-01-30 | Bristol-Myers Squibb Company | Clear antiperspirant roll-on compositions |
US5534246A (en) * | 1994-08-29 | 1996-07-09 | Helene Curtis, Inc. | Topically-effective compositions |
US5919437A (en) * | 1996-05-24 | 1999-07-06 | Colgate-Palmolive Company | Cosmetic cream composition containing silicone gel material |
US5925338A (en) * | 1997-01-29 | 1999-07-20 | The Gillette Company | Clear antiperspirant or deodorant gel composition with volatile linear silicone to reduce staining |
WO1998032418A1 (en) * | 1997-01-29 | 1998-07-30 | The Gillette Company | Clear antiperspirant or deodorant gel composition with volatile linear silicone to reduce staining |
US6685952B1 (en) | 1999-06-25 | 2004-02-03 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Personal care compositions and methods-high internal phase water-in-volatile silicone oil systems |
WO2001047488A3 (en) * | 1999-12-24 | 2002-01-24 | Henkel Kgaa | Antiperspirant composition that contains a water-soluble antiperspirant active agent |
WO2001047476A3 (en) * | 1999-12-24 | 2002-06-06 | Henkel Kgaa | Antiperspirant composition |
US20040109833A1 (en) * | 2002-12-09 | 2004-06-10 | Xiaozhong Tang | High efficacy, low irritation aluminum salts and related products |
US20050158261A1 (en) * | 2002-12-09 | 2005-07-21 | Xiaozhong Tang | High efficacy, low irritation aluminum salts and related products |
US7311898B2 (en) | 2002-12-09 | 2007-12-25 | Colgate-Palmolive Company | High efficacy, low irritation aluminum salts and related products |
US20070190012A1 (en) * | 2004-04-15 | 2007-08-16 | Dow Corning S.A. | Low molecular weight silicone oil-in-water emulsion |
WO2007124889A2 (en) | 2006-04-28 | 2007-11-08 | Henkel Ag & Co. Kgaa | Quick-drying cosmetic emulsions for roll-on application |
Also Published As
Publication number | Publication date |
---|---|
CA1208136A (en) | 1986-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4499069A (en) | Antiperspirant emulsion | |
US4526780A (en) | Anhydrous antiperspirant composition | |
US5188823A (en) | Antiperspirant formulations | |
US4331609A (en) | Antiperspirant composition | |
US5840287A (en) | Antiperspirant compositions containing gellants in the form of alkyl amides of di- and tri-carboxylic acids | |
CA1314212C (en) | Stable parmaceutical w/o emulsion composition | |
US5534246A (en) | Topically-effective compositions | |
US4673570A (en) | Gelled antiperspirant compositions | |
KR100412961B1 (en) | Antiperspirant compositions containing 1,2-hexanediol | |
US6190673B1 (en) | Gel compositions containing gellants in the form of alkyl amides of tri-carboxylic acids | |
US6045784A (en) | Aerosol package compositions containing fluorinated hydrocarbon propellants | |
US4563346A (en) | Topical delivery system and skin treatment compositions employing such system | |
US4425328A (en) | Solid antiperspirant stick composition | |
US6139824A (en) | Deodorant composition | |
EP0211550A2 (en) | Composition for personal care products comprising alkoxylated fatty alcohol and polysiloxane | |
WO1998013014A1 (en) | Aerosol antiperspirant composition | |
AU7048191A (en) | Antiperspirant | |
CZ20033133A3 (en) | Two-phase roll-on cosmetic composition | |
EP1322283B1 (en) | Personal care product | |
EP0117070B1 (en) | Cosmetic sticks | |
NO159695B (en) | WATER-FREE ANTITRANSPIRATION AND / OR DEODORANT CREAM AND PREPARATION OF THIS. | |
US6083493A (en) | Antiperspirant compositions containing isopropyl glycerol ether | |
EP0330140A2 (en) | Hybrid antiperspirant compositions | |
EP0272354A1 (en) | Antiperspirant product | |
EP0452968B1 (en) | Surface modified aluminum and aluminum-zirconium salts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: GILLETTE COMPANY THE; GILLETTE PARK, BOSTON, MA. Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:KRAFTON, THOMAS J.;REEL/FRAME:004113/0469 Effective date: 19830202 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
CC | Certificate of correction | ||
FPAY | Fee payment |
Year of fee payment: 4 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
FPAY | Fee payment |
Year of fee payment: 12 |